$422.00 - $422.00
Substance P (1-9) is the N-terminal nonapeptide Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-OH. Unlike native Substance P, it lacks Leu10 and the amidated Met11 residue that form part of the C-terminal tachykinin receptor pharmacophore.
SP(1-9) is therefore best used as a Substance P degradation and N-terminal fragment reagent rather than as a direct replacement for the native NK1 agonist. Its distinct terminal chemistry is particularly relevant in protease, metabolite-identification and fragment-signaling experiments.
Product Information
| Product Name | Substance P (1-9) |
| CAS No. | 57468-17-4 |
| Sequence | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-OH |
| One-Letter Sequence | RPKPQQFFG |
| Peptide Length | 9 residues |
| Molecular Formula | C52H77N15O12 |
| Molecular Weight | Approximately 1104.3 Da |
| C-Terminus | Gly-OH |
Loss of Leu10-Met11-NH2
SP(1-9) removes the terminal Leu-Met-NH2 portion of native Substance P. The resulting fragment no longer contains the complete C-terminal tachykinin pharmacophore.
This structural difference should be considered when designing receptor experiments because the fragment is chemically and pharmacologically distinct from full-length Substance P.
Research Applications
Substance P (1-9) can support peptide degradation studies, protease assays, LC-MS/MS metabolite identification and investigations of N-terminal Substance P fragment biology.
Frequently Asked Questions
Is SP(1-9) amidated?
No. It terminates in Gly-OH.
Does it contain Met11?
No.
Should it be used as an NK1 agonist control?
Not as a direct substitute for full-length Substance P because the native C-terminal pharmacophore is incomplete.